Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Gabapentin

Apo-Gabapentin :
Type Medicine Authorised
Originator Neurontin 300mg*
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC N03AX12

Your comment will appear shortly after approval

Apo-Gabapentin :

Revision Date :


Effect Frequency
Abdominal pain Common
Abrasion Common
Accidental injury Common
Acne Common
Aggressiveness Common
Allergic reaction Uncommon
Alopecia Not known
ALT increased Uncommon
Amblyopia Common
Amnesia Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Common
Anorgasmia Not known
Anxiety Common
Arthralgia (Pain joint) (Joint ache) Common
AST increased Uncommon
Asthenia Common
Ataxia Very Common
Back pain Common
Blood bilirubin increased Uncommon
Blood creatine phosphokinase increased Not known
Bronchitis Common
Cephalea Common
Chest pain Not known
Choreoathetosis Not known
Confusion Common
Consciousness loss Rare
Constipation Common
Convulsion Common
Coordination disturbance Common
Cough Common
Depression Common
Diarrhoea (Diarrhea) Common
Diplopia Common
Dry mouth (Xerostomia) Common
Dry throat Common
Dysarthria Common
Dyskinesia Not known
Dyspepsia Common
Dyspnoea (dyspnea) Common
Dystonia Not known
Ejaculation disorder Not known
Emotional lability Common
Eosinophilia Not known
Erythema multiforme Not known
Face oedema Common
Fall Uncommon
Fatigue Very Common
Fever Very Common
Flatulence Common
Flu Syndrome Common
Fracture Common
Gait disturbance Common
Generalized oedema Uncommon
Gingivitis Common
Gynecomastia (Gynaecomastia) Not known
Hallucination Not known
Hepatitis Not known
Hyperglycaemia Uncommon
Hyperkinesia Common
Hypersensitivity Not known
Hypertension Common
Hypoesthesia Common
Hypoglycaemia Rare
Hypokinesia Uncommon
Hyponatraemia (Hyponatremia) Not known
Impotence Common
Increased appetite Common
Infection Common
Insomnia Common
Jaundice Not known
Leucopenia (Leukopenia) Common
Leukocyte count decreased (White blood cell count decreased) Common
Libido disorder Not known
Lightheadedness Very Common
Malaise Common
Mammary hypertrophy Not known
Mental impairment Uncommon
Muscle contractions involuntary Common
Myalgia Common
Myoclonus Not known
Nausea Common
Nervousness Common
Nystagmus Common
Oedema peripheral Common
Otitis media Common
Pain Common
Palpitations Uncommon
Pancreatitis Not known
Paraesthesia (paresthesia) Common
Pharyngitis Common
Pneumonia Common
Pruritus Common
Purpura Common
Reflexes absent Common
Reflexes decreased Common
Reflexes increased Common
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Not known
Respiratory tract infection Common
Rhabdomyolysis Not known
Rhinitis Common
Skin Eruption Common
Somnolence Very Common
Stevens-Johnson syndrome Not known
Thought disturbances Common
Thrombocytopenia (Thrombopenia) Not known
Tinnitus Not known
Tooth disorder Common
Tremor Common
Urinary incontinence Not known
Urinary tract infection Common
Urticaria Uncommon
Vasodilation Common
Vertigo Common
Viral infection Very Common
Vomiting Common
Weight increased (weight gain) Common
Withdrawal syndrome Not known

Different Units By MoH Code

Revision Date : 05/04/2018

Revision Date : 05/04/2018

Apo-Gabapentin  MoH 6635 :
Form Capsule, hard
Packaging Bottle
Package Size Box of 100
Strength 300mg
Storage Condition 15-30°C Away from moisture
Public Price 2541889,35 L.L.
Stratum B
NSSF ✔
Quarantine ✘
Reg. Number 167485/10
Submission date 01/01/2010
Registration Year 2012
Barcode 771313137942


Price Comparison

● Country: Lebanon
● Form: Capsule, hard
● Package Size: Box of 100
● Public Price: 2541889.35 LBP ( 2,541,889.35 LBP )
● Pack size unit used: 100
● Cost/Unit: 25418,89 LBP ( 25,418.00 LBP )
● Pricing Date: 10/01/2024

● Country: The Netherlands
● Package Size: 100
● Public Price: 24.96 EUR ( 458,766.05 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,2496 EUR ( 0.00 LBP )
● Pharmacy Price: 17.96 EUR ( 330105.698 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 100 cap
● Exfactory Price: 4.07 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Epileptic seizures :
● Cost/Unit: 25418,89 LBP ( 25,418.00 LBP )
● Cost/Day: 76256,67 LBP ( 76,256.00 LBP )
● Cost/Month: 2287700,1 LBP ( 2,287,700.00 LBP )
Neuropathic pain :
● Cost/Unit: 25418,89 LBP ( 25,418.00 LBP )
● Cost/Day: 76256,67 LBP ( 76,256.00 LBP )
● Cost/Month: 2287700,1 LBP ( 2,287,700.00 LBP )
Partial-onset seizures with or without secondarily generalised seizures : (Adults)
● Cost/Unit: 25418,89 LBP ( 25,418.00 LBP )
● Cost/Day: 76256,67 LBP ( 76,256.00 LBP )
● Cost/Month: 2287700,1 LBP ( 2,287,700.00 LBP )
Primary generalized seizures :
● Cost/Unit: 25418,89 LBP ( 25,418.00 LBP )
● Cost/Day: 76256,67 LBP ( 76,256.00 LBP )
● Cost/Month: 2287700,1 LBP ( 2,287,700.00 LBP )
Epileptic seizures :
● Cost/Unit: 0,2496 EUR ( 0.00 LBP )
● Cost/Day: 0,75 EUR ( 0.00 LBP )
● Cost/Month: 22,5 EUR ( 404,361.10 LBP )
Neuropathic pain :
● Cost/Unit: 0,2496 EUR ( 0.00 LBP )
● Cost/Day: 0,75 EUR ( 0.00 LBP )
● Cost/Month: 22,5 EUR ( 404,361.10 LBP )
Partial-onset seizures with or without secondarily generalised seizures : (Adults)
● Cost/Unit: 0,2496 EUR ( 0.00 LBP )
● Cost/Day: 0,75 EUR ( 0.00 LBP )
● Cost/Month: 22,5 EUR ( 404,361.10 LBP )
Primary generalized seizures :
● Cost/Unit: 0,2496 EUR ( 0.00 LBP )
● Cost/Day: 0,75 EUR ( 0.00 LBP )
● Cost/Month: 22,5 EUR ( 404,361.10 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info